Vanita H Mistry, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 9 years
- University of Arizona College of Medicine, 2017
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mistry’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A157556 · Current
Licensed to practise in California · since 2018 · expires 2028-07-31 · University of Arizona College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,632
Medicare paid this office $1,632 for 35 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| X-ray of chest, 2 views | 12 | $261 | $22 |
Who their Medicare patients are
35 Original Medicare patients in 2024. Average age 72 · Health risk score 1.70. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 40% · Depression 31%.
The office billed $24,610, Medicare allowed $2,183 and paid $1,632; for 42 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 35 | 42 | 72 | 1.70 | $24,610 | $1,632 |
| 2023 | 26 | 31 | 70 | 1.48 | $15,206 | $1,002 |
| 2022 | 21 | 26 | 66 | 1.58 | $10,344 | $670 |
| 2021 | 46 | 76 | 74 | 2.57 | $44,730 | $4,656 |
| 2020 | 17 | 27 | 73 | 1.50 | $14,572 | $1,773 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,137 | $77 |
Medicaid work
$562,250 in 2024
Medicaid paid $562,250 for 15,916 billed services this clinician did in 2024, up to 171 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,031 | $518,644 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 77 | $34,286 |
| Short return visit (20+ min) | 2,377 | $4,081 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 95 | $853 |
| Thyroid stimulating hormone (TSH) | 237 | $522 |
| Hemoglobin A1C level | 394 | $486 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 104 | $406 |
| Blood test, lipids (cholesterol and triglycerides) | 199 | $360 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 15 | $350 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 336 | $279 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 19 | $263 |
| HEPATITIS C ANTIBODY | 123 | $252 |
| 2024 | 15,916 | 44 | 171 | $562,250 |
| 2023 | 8,477 | 30 | 145 | $567,012 |
| 2022 | 7,513 | 30 | 155 | $557,197 |
| 2021 | 4,399 | 19 | 132 | $617,831 |
| 2020 | 508 | 3 | 75 | $69,588 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,147 | $554,762 |
| Short return visit (20+ min) | 2,326 | $5,771 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 188 | $1,657 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 91 | $1,144 |
| Return visit (30+ min) | 272 | $935 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 39 | $462 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 116 | $372 |
| Hemoglobin A1C level | 339 | $344 |
| Thyroid stimulating hormone (TSH) | 199 | $283 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 550 | $251 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 263 | $233 |
| Blood test, lipids (cholesterol and triglycerides) | 169 | $233 |
2022
| Clinic visit/encounter, all-inclusive | 1,155 | $545,918 |
| Short return visit (20+ min) | 2,367 | $5,833 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 123 | $1,975 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 59 | $924 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 93 | $783 |
| Thyroid stimulating hormone (TSH) | 116 | $250 |
| Hemoglobin A1C level | 303 | $227 |
| Return visit (30+ min) | 113 | $224 |
| HEPATITIS C ANTIBODY | 115 | $200 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 211 | $187 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 133 | $140 |
| Blood test, lipids (cholesterol and triglycerides) | 118 | $138 |
2021
| Clinic visit/encounter, all-inclusive | 1,314 | $613,623 |
| Short return visit (20+ min) | 1,842 | $2,809 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 70 | $723 |
| Short return visit | 408 | $528 |
| Thyroid stimulating hormone (TSH) | 28 | $35 |
| Blood test, lipids (cholesterol and triglycerides) | 14 | $28 |
| Hemoglobin A1C level | 46 | $20 |
| ELECTROLYTE PANEL | 57 | $14 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 13 | $11 |
| Creatinine; blood | 58 | $10 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 63 | $10 |
| Blood glucose (sugar) level | 58 | $8 |
2020
| Clinic visit/encounter, all-inclusive | 207 | $69,495 |
| Short return visit | 111 | $69 |
| Short return visit (20+ min) | 190 | $24 |
Drugs they prescribed that Part D paid
$465,507
Pharmacies billed $465,507 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (40 of 2,794) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 90% of their opioid prescriptions.
2,203 generic and 538 brand-name prescriptions · $465,507 in drug cost · 23 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 65 | $81,134 | $1,248 |
| Jardiance | 56 | $74,105 | $1,323 |
| Rybelsus | 25 | $45,664 | $1,827 |
| Mounjaro | 21 | $24,476 | $1,166 |
| Trulicity | 11 | $20,984 | $1,908 |
See all 67 drugs
| Ozempic | 65 | $81,134 | $1,248 |
| Jardiance | 56 | $74,105 | $1,323 |
| Rybelsus | 25 | $45,664 | $1,827 |
| Mounjaro | 21 | $24,476 | $1,166 |
| Trulicity | 11 | $20,984 | $1,908 |
| Eliquis | 18 | $19,258 | $1,070 |
| Januvia | 14 | $16,414 | $1,172 |
| Tradjenta | 12 | $14,470 | $1,206 |
| Belbuca | 21 | $11,013 | $524 |
| Buprenorphine-Naloxone | 66 | $10,469 | $159 |
| Suboxone | 13 | $9,775 | $752 |
| Basaglar Kwikpen U-100 | 24 | $8,661 | $361 |
| Ultra-Fine Mini Pen Needle | 29 | $2,985 | $103 |
| Novolog Mix 70-30 Flexpen | 13 | $2,937 | $226 |
| Albuterol Sulfate Hfa | 39 | $1,415 | $36 |
| Atorvastatin | 235 | $1,330 | $6 |
| Gabapentin | 106 | $1,144 | $11 |
| Buprenorphine | 13 | $894 | $69 |
| Ultra-Fine Short Pen Needle | 12 | $869 | $72 |
| Losartan | 72 | $695 | $10 |
| Metformin | 98 | $689 | $7 |
| Levothyroxine | 59 | $679 | $12 |
| Fosinopril | 33 | $610 | $18 |
| Diclofenac | 39 | $552 | $14 |
| Duloxetine | 24 | $535 | $22 |
| Tamsulosin | 47 | $459 | $10 |
| Hydroxyzine | 36 | $423 | $12 |
| Amlodipine Besylate | 132 | $356 | $3 |
| Ketoconazole | 29 | $341 | $12 |
| Hydralazine | 24 | $318 | $13 |
| Furosemide | 55 | $303 | $6 |
| Rosuvastatin | 20 | $302 | $15 |
| Levetiracetam | 11 | $301 | $27 |
| Glipizide Er | 23 | $300 | $13 |
| Lisinopril | 72 | $256 | $4 |
| Omeprazole | 34 | $234 | $7 |
| Famotidine | 45 | $233 | $5 |
| Trazodone | 34 | $232 | $7 |
| Finasteride | 20 | $207 | $10 |
| Glipizide | 28 | $207 | $7 |
| Potassium Chloride | 13 | $203 | $16 |
| Metformin Hcl Er | 20 | $197 | $10 |
| Fluticasone Propionate | 30 | $181 | $6 |
| Promethazine | 12 | $175 | $15 |
| Hydrochlorothiazide | 61 | $172 | $3 |
| Ciclopirox | 11 | $166 | $15 |
| Metoprolol | 12 | $159 | $13 |
| Simvastatin | 29 | $149 | $5 |
| Baclofen | 20 | $142 | $7 |
| Montelukast | 24 | $140 | $6 |
| Pregabalin | 16 | $133 | $8 |
| Hydrocortisone | 18 | $130 | $7 |
| Chlorthalidone | 11 | $126 | $11 |
| Carvedilol | 26 | $126 | $5 |
| Pravastatin | 16 | $123 | $8 |
| Metoprolol | 28 | $114 | $4 |
| Alendronate | 11 | $112 | $10 |
| Ibuprofen | 31 | $104 | $3 |
| Isosorbide Mononitrate Er | 11 | $97 | $9 |
| Tizanidine | 12 | $97 | $8 |
| Allopurinol | 12 | $81 | $7 |
| Atenolol | 17 | $76 | $4 |
| Naproxen | 12 | $74 | $6 |
| Acyclovir | 11 | $72 | $7 |
| Clopidogrel | 12 | $70 | $6 |
| Pantoprazole | 12 | $68 | $6 |
| Citalopram Hbr | 15 | $54 | $4 |
Year by year
| 2024 | 2,794 | 305 | 1% (40) | 19% | $465,507 |
| 2023 | 2,285 | 280 | 2% (37) | 20% | $410,605 |
| 2022 | 1,968 | 301 | 5% (104) | 19% | $256,544 |
| 2021 | 863 | 220 | 4% (30) | None | $82,137 |
| 2020 | 277 | 57 | None | None | $21,408 |
| 2019 | 354 | 52 | None | None | $21,075 |
| 2018 | 38 | 14 | None | None | $755 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Rybelsus | 49 | $71,520 | $1,460 |
| Trulicity | 40 | $49,158 | $1,229 |
| Jardiance | 37 | $46,385 | $1,254 |
| Ozempic | 21 | $21,298 | $1,014 |
| Suboxone | 23 | $18,826 | $819 |
| Januvia | 13 | $18,206 | $1,400 |
| Eliquis | 18 | $14,303 | $795 |
| Novolog Flexpen | 23 | $13,470 | $586 |
| Basaglar Kwikpen U-100 | 27 | $13,018 | $482 |
| Buprenorphine-Naloxone | 36 | $10,063 | $280 |
| Flovent Hfa | 13 | $4,300 | $331 |
| Atorvastatin | 160 | $3,728 | $23 |
| Gabapentin | 81 | $3,651 | $45 |
| Ultra-Fine Mini Pen Needle | 31 | $3,542 | $114 |
| Metformin | 101 | $2,025 | $20 |
| Amlodipine Besylate | 107 | $1,757 | $16 |
| Losartan | 73 | $1,727 | $24 |
| Diclofenac | 62 | $1,397 | $23 |
| Sodium Chloride | 25 | $1,379 | $55 |
| Lisinopril | 75 | $1,152 | $15 |
| Albuterol Sulfate Hfa | 30 | $1,013 | $34 |
| Levothyroxine | 52 | $798 | $15 |
| Buprenorphine | 18 | $797 | $44 |
| Metoprolol | 28 | $790 | $28 |
| Glipizide | 28 | $690 | $25 |
| Carvedilol | 26 | $668 | $26 |
| Tamsulosin | 36 | $640 | $18 |
| Simvastatin | 32 | $587 | $18 |
| Duloxetine | 29 | $562 | $19 |
| Fosinopril | 21 | $546 | $26 |
| Omeprazole | 33 | $477 | $14 |
| Trazodone | 26 | $441 | $17 |
| Ketoconazole | 20 | $348 | $17 |
| Hydralazine | 17 | $345 | $20 |
| Furosemide | 35 | $312 | $9 |
| Hydroxyzine | 19 | $289 | $15 |
| Metoprolol | 28 | $279 | $10 |
| Rosuvastatin | 24 | $276 | $12 |
| Pravastatin | 12 | $259 | $22 |
| Fluticasone Propionate | 20 | $242 | $12 |
| Baclofen | 11 | $233 | $21 |
| Finasteride | 22 | $233 | $11 |
| Hydrochlorothiazide | 58 | $226 | $4 |
| Allopurinol | 11 | $223 | $20 |
| Glipizide Er | 11 | $216 | $20 |
| Atenolol | 12 | $215 | $18 |
| Isosorbide Mononitrate Er | 12 | $178 | $15 |
| Famotidine | 21 | $176 | $8 |
| Estradiol | 11 | $160 | $15 |
| Montelukast | 21 | $148 | $7 |
| Ibuprofen | 23 | $130 | $6 |
| Citalopram Hbr | 11 | $99 | $9 |
| Latanoprost | 12 | $86 | $7 |
2022: 50 drugs
| Jardiance | 40 | $46,187 | $1,155 |
| Trulicity | 25 | $22,530 | $901 |
| Buprenorphine-Naloxone | 46 | $14,460 | $314 |
| Rybelsus | 14 | $14,396 | $1,028 |
| Januvia | 14 | $13,464 | $962 |
| Suboxone | 18 | $12,921 | $718 |
| Belbuca | 16 | $9,742 | $609 |
| Novolog Flexpen | 15 | $8,254 | $550 |
| Basaglar Kwikpen U-100 | 14 | $7,797 | $557 |
| Buprenorphine | 20 | $6,884 | $344 |
| Anoro Ellipta | 13 | $6,256 | $481 |
| Flovent Hfa | 14 | $4,341 | $310 |
| Lantus Solostar | 13 | $3,873 | $298 |
| Gabapentin | 70 | $2,386 | $34 |
| Atorvastatin | 122 | $1,686 | $14 |
| Ultra-Fine Mini Pen Needle | 15 | $1,599 | $107 |
| Diclofenac | 63 | $1,224 | $19 |
| Levothyroxine | 61 | $1,164 | $19 |
| Sodium Chloride | 23 | $1,045 | $45 |
| Amlodipine Besylate | 103 | $983 | $10 |
| Albuterol Sulfate Hfa | 21 | $864 | $41 |
| Metformin | 113 | $838 | $7 |
| Losartan | 64 | $670 | $10 |
| Omeprazole | 38 | $606 | $16 |
| Metoprolol | 23 | $598 | $26 |
| Oxycodone-Acetaminophen | 11 | $470 | $43 |
| Irbesartan | 11 | $469 | $43 |
| Rosuvastatin | 16 | $468 | $29 |
| Tamsulosin | 32 | $441 | $14 |
| Morphine Sulfate Er | 12 | $438 | $36 |
| Baclofen | 15 | $401 | $27 |
| Duloxetine | 21 | $392 | $19 |
| Famotidine | 17 | $278 | $16 |
| Hydrochlorothiazide | 53 | $253 | $5 |
| Furosemide | 40 | $249 | $6 |
| Lisinopril | 47 | $245 | $5 |
| Glipizide | 22 | $238 | $11 |
| Hydrocodone-Acetaminophen | 13 | $231 | $18 |
| Metoprolol | 24 | $217 | $9 |
| Simvastatin | 15 | $208 | $14 |
| Finasteride | 22 | $205 | $9 |
| Ondansetron | 15 | $197 | $13 |
| Fosinopril | 11 | $172 | $16 |
| Pantoprazole | 15 | $151 | $10 |
| Trazodone | 12 | $137 | $11 |
| Fluticasone Propionate | 15 | $113 | $8 |
| Naproxen | 20 | $112 | $6 |
| Latanoprost | 12 | $101 | $8 |
| Ibuprofen | 18 | $80 | $4 |
| Tramadol | 17 | $75 | $4 |
2021: 19 drugs
| Trulicity | 26 | $22,482 | $865 |
| Jardiance | 17 | $14,247 | $838 |
| Diclofenac | 34 | $1,006 | $30 |
| Albuterol Sulfate Hfa | 16 | $723 | $45 |
| Atorvastatin | 46 | $689 | $15 |
| Levothyroxine | 31 | $543 | $18 |
| Gabapentin | 36 | $463 | $13 |
| Amlodipine Besylate | 61 | $316 | $5 |
| Omeprazole | 26 | $271 | $10 |
| Famotidine | 18 | $266 | $15 |
| Losartan | 23 | $220 | $10 |
| Cyclobenzaprine | 11 | $200 | $18 |
| Lisinopril | 19 | $152 | $8 |
| Fluticasone Propionate | 13 | $147 | $11 |
| Metformin | 27 | $136 | $5 |
| Ondansetron | 11 | $117 | $11 |
| Hydrochlorothiazide | 26 | $95 | $4 |
| Ibuprofen | 19 | $66 | $3 |
| Furosemide | 14 | $58 | $4 |
2020: 7 drugs
| Januvia | 12 | $5,971 | $498 |
| Atorvastatin | 27 | $264 | $10 |
| Levothyroxine | 17 | $177 | $10 |
| Lisinopril | 28 | $101 | $4 |
| Metformin | 11 | $53 | $5 |
| Furosemide | 12 | $47 | $4 |
| Hydrochlorothiazide | 15 | $17 | $1 |
2019: 10 drugs
| Atorvastatin | 27 | $252 | $9 |
| Metoprolol | 14 | $238 | $17 |
| Sertraline | 22 | $212 | $10 |
| Lisinopril | 33 | $115 | $3 |
| Carvedilol | 14 | $106 | $8 |
| Omeprazole | 14 | $98 | $7 |
| Metformin | 15 | $70 | $5 |
| Furosemide | 15 | $62 | $4 |
| Amlodipine Besylate | 11 | $40 | $4 |
| Metoprolol | 13 | $27 | $2 |
Professional record
- NPI
- 1801327010
- Licence
- CA A157556California A157556: Current · expires 2028-07-31
- Trained
- University of Arizona College of Medicine, 2017 · 9 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 2400 Moorpark Ave Ste 220b, San Jose, CA, 95128
- NPI first listed
- 2017-03-21
- NPI last updated
- 2020-09-18
- NPI record certified
- 2020-09-18
This is when the NPI record was last certified, not a medical board exam.